LBP Leadership Position List Labs as a pioneer in live biotherapeutic product development and cGMP microbial manufacturing, highlighting their track record as the first CDMO to produce an LBP for clinical trials to attract partners seeking early-stage to clinical-stage biotherapeutic programs.

Vertical Integration Emphasize end-to-end capabilities from strain development and fermentation to analytical testing, aseptic filling, purification, encapsulation, and scalable manufacturing to target biotech and pharma teams looking for a single trusted supplier.

Research Products Market List Labs' extensive catalog of bacterial-derived reagents and toxins (LPS, toxins, toxoids) as a complementary revenue stream for labs requiring high-quality reference materials, assay development help, and specialized components for microbiome and infectious disease research.

Strategic Partnerships Leverage past and ongoing collaborations with Genome & Company and BetterLife Pharma to demonstrate a proven partnership model for international and translational programs, and to attract clients seeking global manufacturing capabilities.

Financial & Scale Highlight mid-market revenue potential and established customer base (biotech, pharma, and research institutions) to engage mid-to-large biotech firms seeking reliable CDMO capacity, with emphasis on flexibility, compliance, and readiness for clinical-to-commercial transition.